Business
ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
TORONTO, Nov. 20 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and...
About this update from Affinity Metals Corp
[{"type":"text","content":"\n\n\n\nTORONTO, Nov. 20 /CNW/ - ARIUS Research Inc., (TSX: ARI), a biotechnology\ncompany discovering and developing the next wave of antibody therapeutics,\ntoday announced that Daniel S. Pereira, Ph.D., Vice President of Research,\nwill present at the 14th Annual BioNorth Biotechnology and Life Sciences\nConference. Dr. Pereira will present on ARIUS' non-traditional approach to\ndrug discovery using its proprietary FunctionFIRST(TM) technology.\n\n\nThe conference is being held at the Ottawa Congress Centre in Ottawa,\nOntario and ARIUS' presentation is scheduled for Tuesday, November 20th at\n10:30am EST in Capital Hall 1B. Additional information about the 14th Annual\nBioNorth Biotechnology and Life Sciences Conference can be found at:\nwww.bionorth.ca\n\n\nAbout ARIUS\n\n\nARIUS is a biotechnology company discovering and developing the next wave\nof antibody therapeutics. Established in 1999, ARIUS has built a proprietary\ntechnology platform, FunctionFIRST(TM), that rapidly identifies and selects\nantibodies based on their functional ability to affect disease. This antibody\ngeneration engine has enabled ARIUS to assemble a portfolio of more than 500\nantibody candidates. In addition to the antibodies it is developing in-house,\nARIUS has ongoing partnerships with key biotechnology and drug development\ncompanies. ARIUS is listed on the TSX under the symbol "ARI". For further\ninformation, visit www.ariusmabs.com\n\n\nForward-Looking Statements\n\n\nCertain statements in this news release constitute "forward-looking\nstatements" within the meaning of the Private Securities Litigation Reform Act\nof 1995, which involve known and unknown risks, uncertainties and other\nfactors that may cause our actual results to be materially different from any\nfuture results, performance or achievements expressed or implied by such\nstatements. Forward-looking statements in this release include, but are not\nlimited to, ARIUS successfully advancing its new product programs as well as\nlicensing opportunities. These statements are only predictions and actual\nevents or results may differ materially. Factors that could cause such actual\nevents or results expressed or implied by such forward-looking statements to\ndiffer materially from any future results expressed or implied by such\nstatements include, but are not lim...